Abnormal calcium homeostasis in heart failure with preserved ejection fraction is related to both reduced contractile function and incomplete relaxation: an electromechanically detailed biophysical modeling study

Ismail Adeniran, David H MacIver, Jules C Hancox, Henggui Zhang, Ismail Adeniran, David H MacIver, Jules C Hancox, Henggui Zhang

Abstract

Heart failure with preserved ejection fraction (HFpEF) accounts for about 50% of heart failure cases. It has features of incomplete relaxation and increased stiffness of the left ventricle. Studies from clinical electrophysiology and animal experiments have found that HFpEF is associated with impaired calcium homeostasis, ion channel remodeling and concentric left ventricle hypertrophy (LVH). However, it is still unclear how the abnormal calcium homeostasis, ion channel and structural remodeling affect the electro-mechanical dynamics of the ventricles. In this study we have developed multiscale models of the human left ventricle from single cells to the 3D organ, which take into consideration HFpEF-induced changes in calcium handling, ion channel remodeling and concentric LVH. Our simulation results suggest that at the cellular level, HFpEF reduces the systolic calcium level resulting in a reduced systolic contractile force, but elevates the diastolic calcium level resulting in an abnormal residual diastolic force. In our simulations, these abnormal electro-mechanical features of the ventricular cells became more pronounced with the increase of the heart rate. However, at the 3D organ level, the ejection fraction of the left ventricle was maintained due to the concentric LVH. The simulation results of this study mirror clinically observed features of HFpEF and provide new insights toward the understanding of the cellular bases of impaired cardiac electromechanical functions in heart failure.

Keywords: 3D model; calcium; heart failure; ventricle.

Figures

Figure 1
Figure 1
Geometry and fiber directions in 3D left ventricle with varied wall thickness. (A) Control and HFpEF concentric hypertrophic geometries—NORMAL (green, 9 mm), MILD (red, 12 mm), MODERATE (blue, 15 mm) and SEVERE (yellow, 18 mm). (B) Fiber direction. (C) Sheet direction. (D) Sheet-normal or cross-sheet direction.
Figure 2
Figure 2
Force-pCa relationship. Simulated Force-pCa relation of control and HFpEF. Relative force is normalized to maximum value in control. Inset: Experimental force-pCa relation from human patients adopted from Borbély et al. (2005).
Figure 3
Figure 3
Single cell simulations of HFpEF. (Ai–Ci) Control (black) and HFpEF (green) action potentials in the EPI (Ai), MCELL (Bi), and ENDO (Ci) cell models. (Aii–Cii) Control (black) and HFpEF (green) cytosolic Ca2+ concentration in the EPI (Aii), MCELL (Bii), and ENDO (Cii) cell models. (Aiii–Ciii) Control (black) and HFpEF (green) sarcomere length (SL) in the EPI (Aiii), MCELL (Biii), and ENDO (Ciii) cell models. (Aiv–Civ) Control (black) and HFpEF (green) active force in the EPI (Aiv), MCELL (Biv), and ENDO (Civ) cell models. Values are normalized to Control maximum active force for each cell type.
Figure 4
Figure 4
Effects of HFpEF and HFrEF on underlying ion channel currents, concentrations and force generation. (A) Control (black), HFpEF (green), and HFrEF (red) action potentials. (B)ICaL current profile in control (black), HFpEF (green), and HFrEF (red). (C)INaCa current profile in control (black), HFpEF (green), and HFrEF (red). (D) SR Ca2+ content profile in control (black), HFpEF (green), and HFrEF (red). (E)IpCa current profile in control (black), HFpEF (green), and HFrEF (red). (F) [Na]i time course in control (black), HFpEF (green), and HFrEF (red). (G) [K]i time course in control (black), HFpEF (green), and HFrEF (red). (H)INaK current profile in control (black) HFpEF (green), and HFrEF (red). (I)Jup (Ca2+ uptake via SERCA pump) profile in control (black), HFpEF (green), and HFrEF (red). (J) Ca2+ concentration in Control (black) HFpEF (green), and HFrEF (red) cytosolic. (K) Sarcomere length (SL) in control (black), HFpEF (green), and HFrEF (red). (L) Active force in control (black), HFpEF (green), and HFrEF (red). Values are normalized to Control maximum active force.
Figure 5
Figure 5
Ca2+ handling and post-rest properties in HFpEF. (Ai,Bi) Diastolic Ca2+ level in HFpEF relative to control at 1 Hz (Ai) and 2 Hz (Bi) pacing rates. (Aii,Bii) SR Ca2+ content level in HFpEF relative to control at 1 Hz (Aii) and 2 Hz (Bii) pacing rates. (Aiii,Biii) Resting tension in HFpEF relative to control at 1 Hz (Aiii) and 2 Hz (Biii) pacing rates. (Aiv,Biv) Peak systolic tension in HFpEF relative to control at 1 Hz (Aiv) and 2 Hz (Biv) pacing rates. (Av,Bv) SR Ca2+ Ca leak in HFpEF relative to control at 1 Hz (Av) and 2 Hz (Bv) pacing rates.
Figure 6
Figure 6
HFpEF Model sensitivity to increasing NCX activity and its influence on incomplete relaxation in the cellular model. Simulation results were compared between control (in absence of ionic current remodeling) and HFpEF condition. HFpEF simulations were performed with parameters as listed in Table 1, but with NCX activity changing from 70% (HFpEF condition) to 100, 150, and 175% (HFrEF condition) of the control value. (A) Action potential (B)INaCa current profile. (C) Ca2+ concentration. (D) Active force. Values are normalized to maximum active force in control. (Inset: magnified diastolic phase).
Figure 7
Figure 7
Effects of HFpEF on 3D electro-mechanics. Electrical wave propagation and mechanical contraction at 0, 200, 300, and 700 ms in NORMAL, MILD, MODERATE, and SEVERE HFpEF hypertrophic cases. (Far right) Ejection fraction in NORMAL, MILD, MODERATE, and SEVERE HFpEF hypertrophic cases.
Figure 8
Figure 8
Effects of HFpEF on stress magnitude distribution. Stress magnitude distribution at 0 ms (A), 100 ms (B), 200 ms (C), 300 ms (D), 400 ms (E) 600 ms (F), and 700 ms (G) in NORMAL, MILD, MODERATE, and SEVERE hypertrophic HFpEF cases.
Figure 9
Figure 9
Effects of HFpEF on strain magnitude distribution. Strain magnitude distribution at 0 ms (A), 100 ms (B), 200 ms (C), 300 ms (D), 400 ms (E) 600 ms (F), and 700 ms (G) in NORMAL, MILD, MODERATE, and SEVERE hypertrophic HFpEF cases.

References

    1. Adeniran I., Hancox J. C., Zhang H. (2013a). Effect of cardiac ventricular mechanical contraction on the characteristics of the ECG: a simulation study. J. Biomed. Sci. Eng. 6, 47–60 10.4236/jbise.2013.612A007
    1. Adeniran I., Hancox J., Zhang H. (2013b). In silico investigation of the short QT syndrome, using human ventricle models incorporating electromechanical coupling. Front. Physiol. 4:166 10.3389/fphys.2013.00166
    1. Alan C., Hindmarsh P. N. B. (2005). SUNDIALS: suite of nonlinear and differential/algebraic equation solvers. ACM Trans. Math. Softw. 31, 363–396 10.1145/1089014.1089020
    1. Ambrosi D., Arioli G., Nobile F., Quarteroni A. (2011). Electromechanical coupling in cardiac dynamics: the active strain approach. SIAM J. Appl. Math. 71, 605–621 10.1137/100788379
    1. Asrar Ul Haq M., Mutha V., Rudd N., Hare D. L., Wong C. (2014). Heart failure with preserved ejection fraction—unwinding the diagnosis mystique. Am. J. Cardiovasc. Dis. 4, 100–113.
    1. Auricchio F., Beirão da Veiga L., Lovadina C., Reali A. (2010). The importance of the exact satisfaction of the incompressibility constraint in nonlinear elasticity: mixed FEMs versus NURBS-based approximations. Comput. Methods Appl. Mech. Eng. 199, 314–323 10.1016/j.cma.2008.06.004
    1. Barry W. H., Bridge J. H. (1993). Intracellular calcium homeostasis in cardiac myocytes. Circulation 87, 1806–1815. 10.1161/01.CIR.87.6.1806
    1. Barry W. H., Hasin Y., Smith T. W. (1985). Sodium pump inhibition, enhanced calcium influx via sodium-calcium exchange, and positive inotropic response in cultured heart cells. Circ. Res. 56, 231–241. 10.1161/01.RES.56.2.231
    1. Bers D. (2001). Excitation-Contraction Coupling and Cardiac Contractile Force, 2nd Edn. Dordrecht: Springer.
    1. Bhatia R. S., Tu J. V., Lee D. S., Austin P. C., Fang J., Haouzi A., et al. . (2006). Outcome of heart failure with preserved ejection fraction in a population-based study. N. Engl. J. Med. 355, 260–269. 10.1056/NEJMoa051530
    1. Boffi D., Brezzi F., Fortin M. (2013). Mixed Finite Element Methods and Applications, 2013 Edn. New York, NY: Springer.
    1. Bogaert J., Rademakers F. E. (2001). Regional nonuniformity of normal adult human left ventricle. Am. J. Physiol. Heart Circ. Physiol. 280, H610–H620.
    1. Bonet J., Wood R. D. (2008). Nonlinear Continuum Mechanics for Finite Element Analysis, 2nd Edn. New York, NY: Cambridge University Press.
    1. Borbély A., van der Velden J., Papp Z., Bronzwaer J. G., Edes I., Stienen G. J., et al. . (2005). Cardiomyocyte stiffness in diastolic heart failure. Circulation 111, 774–781. 10.1161/01.CIR.0000155257.33485.6D
    1. Borlaug B. A., Paulus W. J. (2010). Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur. Heart J. 32, 670–679. 10.1093/eurheartj/ehq426
    1. Braess D. (2007). Finite Elements: Theory, Fast Solvers, and Applications in Solid Mechanics, 3rd Edn. New York, NY: Cambridge University Press.
    1. Braess D., Ming P. (2005). A finite element method for nearly incompressible elasticity problems. Math. Comput. 74, 25–52 10.1090/S0025-5718-04-01662-X
    1. Brenner S. C., Scott R. (2010). The Mathematical Theory of Finite Element Methods, 3rd Edn. 2008. New York, NY: Springer.
    1. Bueno-Orovio A., Sánchez C., Pueyo E., Rodriguez B. (2014). Na/K pump regulation of cardiac repolarization: insights from a systems biology approach. Pflügers. Arch. Eur. J. Physiol. 466, 183–193. 10.1007/s00424-013-1293-1
    1. Burkhoff D., Yue D. T., Franz M. R., Hunter W. C., Sagawa K. (1984). Mechanical restitution of isolated perfused canine left ventricles. Am. J. Physiol. 246, H8–H16.
    1. Burnett D. S. (1987). Finite Element Analysis: From Concepts to Applications, 1st Edn. Reading, MA: Addison Wesley.
    1. Chamberland E., Fortin A., Fortin M. (2010). Comparison of the performance of some finite element discretizations for large deformation elasticity problems. Comput. Struct. 88, 664–673 10.1016/j.compstruc.2010.02.007
    1. Cherubini C., Filippi S., Nardinocchi P., Teresi L. (2008). An electromechanical model of cardiac tissue: constitutive issues and electrophysiological effects. Prog. Biophys. Mol. Biol. 97, 562–573. 10.1016/j.pbiomolbio.2008.02.001
    1. Ciarlet P. G. (2002). The Finite Element Method for Elliptic Problems, 2nd Edn. New York, NY: Society for Industrial and Applied Mathematics.
    1. Cohen S., Hindmarsh A. C. (1996). Cvode, a stiff/nonstiff ode solver in C, in C. Computers in Physics, ed Holmes L. M. (New York, NY: American Institute of Physics Inc.), 138–143.
    1. Colli Franzone P., Pavarino L. F., Taccardi B. (2005). Simulating patterns of excitation, repolarization and action potential duration with cardiac Bidomain and Monodomain models. Math. Biosci. 197, 35–66. 10.1016/j.mbs.2005.04.003
    1. Costa K. D., Holmes J. W., McCulloch A. D. (2001). Modelling cardiac mechanical properties in three dimensions. Philos. Trans. R. Soc. Lond. Ser. Math. Phys. Eng. Sci. 359, 1233–1250. 10.1098/rsta.2001.0828
    1. Drouin E., Charpentier F., Gauthier C., Laurent K., Le Marec H. (1995). Electrophysiologic characteristics of cells spanning the left ventricular wall of human heart: evidence for presence of M cells. J. Am. Coll. Cardiol. 26, 185–192. 10.1016/0735-1097(95)00167-X
    1. Ebashi S. (1984). Ca2+ and the contractile proteins. J. Mol. Cell. Cardiol. 16, 129–136. 10.1016/S0022-2828(84)80701-4
    1. Ern A., Guermond J.-L. (2010). Theory and Practice of Finite Elements, 1st Edn. 2004. New York, NY: Springer.
    1. Franz M. R., Schaefer J., Schöttler M., Seed W. A., Noble M. I. (1983). Electrical and mechanical restitution of the human heart at different rates of stimulation. Circ. Res. 53, 815–822. 10.1161/01.RES.53.6.815
    1. Glitsch H. G. (2001). Electrophysiology of the sodium-potassium-ATPase in cardiac cells. Physiol. Rev. 81, 1791–1826.
    1. Gomez J. F., Cardona K., Romero L., Ferrero J. M., Trenor B. (2014). Electrophysiological and structural remodeling in heart failure modulate arrhythmogenesis. 1D simulation study. PLoS ONE 9:e106602. 10.1371/journal.pone.0106602
    1. Haga J. B., Osnes H., Langtangen H. P. (2012). On the causes of pressure oscillations in low-permeable and low-compressible porous media. Int. J. Numer. Anal. Methods Geomech. 36, 1507–1522 10.1002/nag.1062
    1. Heymans S., Schroen B., Vermeersch P., Milting H., Gao F., Kassner A., et al. . (2005). Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart. Circulation 112, 1136–1144. 10.1161/CIRCULATIONAHA.104.516963
    1. Holzapfel G. A. (2000). Nonlinear Solid Mechanics: A Continuum Approach for Engineering, 1st Edn. Chichester: Wiley.
    1. Hughes T. J. R. (2000). The Finite Element Method: Linear Static and Dynamic Finite Element Analysis. New York, NY: Dover Publications.
    1. Keener J., Sneyd J. (2008). Mathematical Physiology: II: Systems Physiology, 2nd Edn. New York, NY: Springer.
    1. Keldermann R. H., Nash M. P., Panfilov A. V. (2009). Modeling cardiac mechano-electrical feedback using reaction-diffusion-mechanics systems. Phys. Nonlinear Phenom. 238, 1000–1007 10.1016/j.physd.2008.08.017
    1. Keller D. U. J., Kalayciyan R., Dössel O., Seemann G. (2009). Fast creation of endocardial stimulation profiles for the realistic simulation of body surface ECGs, in IFMBE Proceedings, 145–148 Available online at: (Accessed July 20, 2011).
    1. Kjørstad K. E., Nordhaug D. O., Korvald C., Müller S., Steensrud T., Myrmel T. (2007). Mechanical restitution curves: a possible load independent assessment of contractile function. Eur. J. Cardio-Thorac. Surg. 31, 677–684. 10.1016/j.ejcts.2007.01.013
    1. Kono M., Kisanuki A., Takasaki K., Nakashiki K., Yuasa T., Kuwahara E., et al. . (2009). Left ventricular systolic function is abnormal in diastolic heart failure: re-assessment of systolic function using cardiac time interval analysis. J. Cardiol. 53, 437–446. 10.1016/j.jjcc.2009.02.014
    1. Konstantinou D. M., Chatzizisis Y. S., Giannoglou G. D. (2013). Pathophysiology-based novel pharmacotherapy for heart failure with preserved ejection fraction. Pharmacol. Ther. 140, 156–166. 10.1016/j.pharmthera.2013.05.012
    1. Lacombe V. A., Viatchenko-Karpinski S., Terentyev D., Sridhar A., Emani S., Bonagura J. D., et al. (2007). Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293, R1787–R1797 10.1152/ajpregu.00059.2007
    1. Le Tallec P. (1994). Numerical methods for nonlinear three-dimensional elasticity, in Handbook of Numerical Analysis, Vol. III, eds Ciarlet P. G., Lions J. L. (North-Holland: Amsterdam; ), 465–622.
    1. Li G. R., Feng J., Yue L., Carrier M. (1998). Transmural heterogeneity of action potentials and Ito1 in myocytes isolated from the human right ventricle. Am. J. Physiol. 275, H369–H377.
    1. Liu Y., Haddad T., Dwivedi G. (2013). Heart failure with preserved ejection fraction: current understanding and emerging concepts. Curr. Opin. Cardiol. 28, 187–196. 10.1097/HCO.0b013e32835c5492
    1. Logg A., Mardal K.-A., Wells G. (eds.) (2012). Automated Solution of Differential Equations by the Finite Element Method: The FEniCS Book, 2012th Edn. Heidelberg: Springer.
    1. MacIver D. H. (2010a). Current controversies in heart failure with a preserved ejection fraction. Future Cardiol. 6, 97–111. 10.2217/fca.09.56
    1. MacIver D. H. (2010b). Is remodeling the dominant compensatory mechanism in both chronic heart failure with preserved and reduced left ventricular ejection fraction? Basic Res. Cardiol. 105, 227–234. 10.1007/s00395-009-0063-x
    1. MacIver D. H. (2011). A new method for quantification of left ventricular systolic function using a corrected ejection fraction. Eur. J. Echocardiogr. 12, 228–234. 10.1093/ejechocard/jeq185
    1. MacIver D. H., Dayer M. J. (2012). An alternative approach to understanding the pathophysiological mechanisms of chronic heart failure. Int. J. Cardiol. 154, 102–110. 10.1016/j.ijcard.2011.05.075
    1. MacIver D. H., Townsend M. (2008). A novel mechanism of heart failure with normal ejection fraction. Heart Br. Card. Soc. 94, 446–449. 10.1136/hrt.2006.114082
    1. Marsden J. E., Hughes T. J. R. (1994). Mathematical Foundations of Elasticity. New Jersey: Dover Publications.
    1. Niederer S. A., Smith N. P. (2008). An improved numerical method for strong coupling of excitation and contraction models in the heart. Prog. Biophys. Mol. Biol. 96, 90–111. 10.1016/j.pbiomolbio.2007.08.001
    1. O'Hara T., Virág L., Varró A., Rudy Y. (2011). Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation. PLoS Comput. Biol. 7:e1002061. 10.1371/journal.pcbi.1002061
    1. Owan T. E., Hodge D. O., Herges R. M., Jacobsen S. J., Roger V. L., Redfield M. M. (2006). Trends in prevalence and outcome of heart failure with preserved ejection fraction. N. Engl. J. Med. 355, 251–259. 10.1056/NEJMoa052256
    1. Pathmanathan P., Whiteley J. P. (2009). A numerical method for cardiac mechanoelectric simulations. Ann. Biomed. Eng. 37, 860–873. 10.1007/s10439-009-9663-8
    1. Phan T. T., Shivu G. N., Abozguia K., Sanderson J. E., Frenneaux M. (2012). The pathophysiology of heart failure with preserved ejection fraction: from molecular mechanisms to exercise haemodynamics. Int. J. Cardiol. 158, 337–343. 10.1016/j.ijcard.2011.06.113
    1. Prabhu S. D., Freeman G. L. (1995). Effect of tachycardia heart failure on the restitution of left ventricular function in closed-chest dogs. Circulation 91, 176–185. 10.1161/01.CIR.91.1.176
    1. Rademakers F. E., Rogers W. J., Guier W. H., Hutchins G. M., Siu C. O., Weisfeldt M. L., et al. . (1994). Relation of regional cross-fiber shortening to wall thickening in the intact heart. Three-dimensional strain analysis by NMR tagging. Circulation 89, 1174–1182. 10.1161/01.CIR.89.3.1174
    1. Redfield M. M., Jacobsen S. J., Burnett J. C., Mahoney D. W., Bailey K. R., Rodeheffer R. J. (2003). Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289, 194–202. 10.1001/jama.289.2.194
    1. Rice J. J., Wang F., Bers D. M., de Tombe P. P. (2008). Approximate model of cooperative activation and crossbridge cycling in cardiac muscle using ordinary differential equations. Biophys. J. 95, 2368–2390. 10.1529/biophysj.107.119487
    1. Robertson S. P., Johnson J. D., Holroyde M. J., Kranias E. G., Potter J. D., Solaro R. J. (1982). The effect of troponin I phosphorylation on the Ca2+-binding properties of the Ca2+-regulatory site of bovine cardiac troponin. J. Biol. Chem. 257, 260–263.
    1. Rossi S., Lassila T., Ruiz-Baier R., Sequeira A., Quarteroni A. (2014). Thermodynamically consistent orthotropic activation model capturing ventricular systolic wall thickening in cardiac electromechanics. Eur. J. Mech. ASolids. 48, 129–142 10.1016/j.euromechsol.2013.10.009
    1. Rush S., Larsen H. (1978). A practical algorithm for solving dynamic membrane equations. IEEE Trans. Biomed. Eng. 25, 389–392. 10.1109/TBME.1978.326270
    1. Sanderson J. E. (2007). Heart failure with a normal ejection fraction. Heart 93, 155–158 10.1136/hrt.2005.074187
    1. Selby D. E., Palmer B. M., LeWinter M. M., Meyer M. (2011). Tachycardia-induced diastolic dysfunction and resting tone in myocardium from patients with a normal ejection fraction. J. Am. Coll. Cardiol. 58, 147–154. 10.1016/j.jacc.2010.10.069
    1. Soma J. (2011). Heart failure with preserved left ventricular ejection fraction: concepts, misconceptions and future directions. Blood Press. 20, 129–133. 10.3109/08037051.2010.542642
    1. Sundnes J., Lines G. T., Tveito A. (2005). An operator splitting method for solving the bidomain equations coupled to a volume conductor model for the torso. Math. Biosci. 194, 233–248. 10.1016/j.mbs.2005.01.001
    1. Taggart P., Sutton P. M., Opthof T., Coronel R., Trimlett R., Pugsley W., et al. . (2000). Inhomogeneous transmural conduction during early ischaemia in patients with coronary artery disease. J. Mol. Cell. Cardiol. 32, 621–630. 10.1006/jmcc.2000.1105
    1. Tran K., Smith N. P., Loiselle D. S., Crampin E. J. (2010). A metabolite-sensitive, thermodynamically constrained model of cardiac cross-bridge cycling: implications for force development during ischemia. Biophys. J. 98, 267–276 10.1016/j.bpj.2009.10.011
    1. Trenor B., Cardona K., Gomez J. F., Rajamani S., Ferrero J. M., Belardinelli L., et al. . (2012). Simulation and mechanistic investigation of the arrhythmogenic role of the late sodium current in human heart failure. PLoS ONE 7:e32659. 10.1371/journal.pone.0032659
    1. Vasan R. S., Levy D. (2000). Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 101, 2118–2121. 10.1161/01.CIR.101.17.2118
    1. Wang J., Khoury D. S., Yue Y., Torre-Amione G., Nagueh S. F. (2008). Preserved left ventricular twist and circumferential deformation, but depressed longitudinal and radial deformation in patients with diastolic heart failure. Eur. Heart J. 29, 1283–1289. 10.1093/eurheartj/ehn141
    1. Whiteley J. P., Bishop M. J., Gavaghan D. J. (2007). Soft tissue modelling of cardiac fibres for use in coupled mechano-electric simulations. Bull. Math. Biol. 69, 2199–2225. 10.1007/s11538-007-9213-1
    1. Wilson L. D., Jennings M. M., Rosenbaum D. S. (2011). Point: M cells are present in the ventricular myocardium. Heart Rhythm 8, 930–933. 10.1016/j.hrthm.2011.01.026
    1. Workman A. J., Kane K. A., Rankin A. C. (2003). Characterisation of the Na, K pump current in atrial cells from patients with and without chronic atrial fibrillation. Cardiovasc. Res. 59, 593–602. 10.1016/S0008-6363(03)00466-8
    1. Yturralde R. F., Gaasch W. H. (2005). Diagnostic criteria for diastolic heart failure. Prog. Cardiovasc. Dis. 47, 314–319. 10.1016/j.pcad.2005.02.007
    1. Zaugg C. E., Kojima S., Wu S. T., Wikman Coffelt J., Parmley W. W., Buser P. T. (1995). 997-86 intracellular calcium transients underlie mechanical restitution in whole rat hearts. J. Am. Coll. Cardiol. 25, 325A 10.1016/0735-1097(95)92811-I
    1. Zile M. R., Baicu C. F., Gaasch W. H. (2004). Diastolic heart failure—abnormalities in active relaxation and passive stiffness of the left ventricle. N. Engl. J. Med. 350, 1953–1959. 10.1056/NEJMoa032566
    1. Zile M. R., Gaasch W. H. (2011). Abnormal calcium homeostasis: one mechanism in diastolic heart failure. J. Am. Coll. Cardiol. 58, 155–157. 10.1016/j.jacc.2010.10.068
    1. Zile M. R., Gaasch W. H., Carroll J. D., Feldman M. D., Aurigemma G. P., Schaer G. L., et al. . (2001). Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation 104, 779–782. 10.1161/hc3201.094226
    1. Zouein F. A., de Castro Brás L. E., da Costa D. V., Lindsey M. L., Kurdi M., Booz G. W. (2013). Heart failure with preserved ejection fraction: emerging drug strategies. J. Cardiovasc. Pharmacol. 62, 13–21. 10.1097/FJC.0b013e31829a4e61

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe